While lung cancer is relatively rare among kidney transplant recipients, it remains a dangerous complication, carrying high rates of metastasis and mortality, according to a Philippine case series presented at the recently concluded 2020 Asia Virtual Congress of the European Society of Medical Oncology (ESMO Asia 2020)
Initiation or switch to the single-tablet regimen of bictegravir/emtricitabine/tenofovir alafenamide (TAF) led to low HIV-1 RNA viral load in people living with HIV (PLHIV), according to the BICSTaR study presented at HIV Glasgow 2020.
The neratinib/capecitabine combination still confers survival advantage over lapatinib plus capecitabine in the subgroup of Asian patients with heavily treated HER2-positive metastatic breast cancer (MBC), according to an exploratory analysis of the phase III NALA trial.
Rosacea, a chronic inflammatory cutaneous disorder associated with multiple systemic illnesses, is associated with hypertension and dyslipidaemia but not with ischaemic heart disease (IHD), stroke, or diabetes, results of a systematic review and meta-analysis have shown.
Reductions in liver fat and adipose tissue volumes were sustained in patients with type 2 diabetes (T2D) with the addition of the SGLT-2* inhibitor dapagliflozin (DAPA) and the DPP-4** inhibitor saxagliptin (SAXA) to metformin (MET), compared with a regimen comprising glimepiride (GLIM)+MET, according to the extension period results of a phase IIIb trial.
Patients with ST-elevation and COVID-19 have different characteristics than those without COVID-19, and may have a higher risk of in-hospital mortality and stroke, according to initial results of the NACMI* registry study presented at TCT Connect 2020.
A topical gel treatment derived from birch bark significantly speeds up wound healing compared with standard care in patients with epidermolysis bullosa (EB) lesions, according to the EASE trial presented at the EADV 2020 Conference — representing the first-ever treatment to show positive results for the rare skin disorder.
Several markers of inflammation hold clue to identifying cancer patients at increased risk of death from COVID-19, according to data from OnCovid reported during the European Society for Medical Oncology (ESMO) Asia Virtual Congress.
Pathologic complete response (pCR) rates have significantly improved in patients with early-stage triple-negative breast cancer (TNBC) on neoadjuvant atezolizumab plus chemotherapy regardless of programmed death-ligand 1 (PD-L1) status, with an acceptable safety profile, relative to those on chemotherapy alone, results from the Impassion031 study have shown.
Diabetes is a key risk factor for heart failure (HF), which is the leading cause of hospitalization in patients with or without diabetes. SGLT-2* inhibitors (SGLT-2is) have been shown to reduce the risk of hospitalization for HF (HHF) regardless of the presence or absence of diabetes.